About John Davidson
Form D filings for Tangen Biosciences from 2015 to 2023 list John Davidson as executive officer and director.
John Davidson first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name John Davidson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Davidson works with at each company, as listed on that company's latest Form D.
Tangen Biosciences, Inc. · Form D, Jun 6, 2023
AL
Alan Levin
Director
RP
Richard Birkmeyer, PhD
President and CEO, director
VK
Vance Kershner
Director
DW
Daniel Wagner
Director
CM
Christopher McLeod
Director